Potent CD4(+) T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition

Por Deppisch, Nina, Ruf, Peter, Eißler, Nina, Lindhofer, Horst, Mocikat, Ralph
Publicado no Oncotarget (2016)

Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy

Por Eissler, Nina, Sveinbjörnsson, Baldur, Kock, Anna, Johnsen, John Inge, Kogner, Per
Publicado no J Immunother Cancer (2014)

Potential of the Trifunctional Bispecific Antibody Surek Depends on Dendritic Cells: Rationale for a New Approach of Tumor Immunotherapy

Por Eissler, Nina, Mysliwietz, Josef, Deppisch, Nina, Ruf, Peter, Lindhofer, Horst, Mocikat, Ralph
Publicado em 2013

Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade

Por Eissler, Nina, Mao, Yumeng, Brodin, David, Reuterswärd, Philippa, Andersson Svahn, Helene, Johnsen, John Inge, Kiessling, Rolf, Kogner, Per
Publicado no Oncoimmunology (2016)

Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model

Por Ruf, Peter, Schäfer, Beatrix, Eissler, Nina, Mocikat, Ralph, Hess, Juergen, Plöscher, Matthias, Wosch, Susanne, Suckstorff, Ivonne, Zehetmeier, Christine, Lindhofer, Horst
Publicado em 2012